Acute heart failure and cardiac arrest are major public health problems in Australia. Each year 1000s of such patients will die, and many others are left with significant disabilities. Extracorporeal membrane oxygenation (ECMO) is a novel form of advanced mechanical cardiac support used in the sickest of these patients. In selected patients, it can be lifesaving. However, it remains a high-risk and costly intervention, costing over AU$300,000 on average per hospital admission. Furthermore, its use has doubled over the last five years despite limited evidence supporting its use. Systematically developing robust, high-quality, patient-centred evidence to define the role of ECMO in acute heart failure and cardiac arrest is an urgent issue of national and international importance.
My fellowship aims to generate high-quality, clinically relevant, feasible and accessible knowledge to inform global practice of ECMO by addressing 3 major evidence-practice gaps:
Building on recently published work defining important core outcomes in ECMO, I will lead an international collaboration to develop measurement tools for a core outcome set.
A comparison of scene versus hospital based ECMO initiation for out of hospital cardiac arrest
Statistics and information on heart failure in Australia
Resources and tools for healthcare professionals to support the management of patients with heart failure.
Last updated12 July 2021